American International Group, Inc. Mei Pharma, Inc. Transaction History

American International Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.65 $26,663 - $41,265	-63,485 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.54 - $2.74 $3,171 - $16,092	5,873 Added 10.19%	63,485 $38,000
Q4 2021 Feb 11, 2022	SELL	$2.33 - $3.37 $4,016 - $5,809	-1,724 Reduced 2.91%	57,612 $154,000
Q3 2021 Nov 12, 2021	SELL	$2.52 - $2.99 $3,553 - $4,215	-1,410 Reduced 2.32%	59,336 $164,000
Q2 2021 Aug 13, 2021	SELL	$2.6 - $3.65 $8,255 - $11,588	-3,175 Reduced 4.97%	60,746 $173,000

Q1 2021 May 07, 2021	BUY	$2.73 - $4.5 $461 - $760	169 Added 0.27%	63,921 $219,000
Q4 2020 Feb 12, 2021	BUY	$2.6 - $3.32 $5,129 - $6,550	1,973 Added 3.19%	63,752 $168,000
Q3 2020 Nov 04, 2020	SELL	$2.46 - $4.27 $3,453 - $5,995	-1,404 Reduced 2.22%	61,779 $193,000
Q2 2020 Aug 12, 2020	BUY	$1.45 - $4.3 $4,640 - $13,760	3,200 Added 5.33%	63,183 $261,000
Q1 2020 May 04, 2020	BUY	$0.75 - $2.55 $11,920 - $40,529	15,894 Added 36.05%	59,983 $97,000
Q4 2019 Feb 05, 2020	BUY	$1.65 - $2.48 $1,744 - $2,621	1,057 Added 2.46%	44,089 $109,000
Q3 2019 Nov 08, 2019	SELL	$1.48 - $2.52 $444 - $756	-300 Reduced 0.69%	43,032 $72,000
Q2 2019 Aug 13, 2019	BUY	$2.45 - $3.32 $106,163 - $143,862	43,332 New	43,332 $109,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $373M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.